Ledger.Open graph →
SEC Form D · filed November 1, 2024

Axonis Therapeutics, Inc

Offering
$115.0M
Sold
$46.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

A. Rich · Boston, MAExec · DirectorDonald J. Manning, M.D., Ph.D · Boston, MAExecJeffrey Imbaro · Boston, MAExecCorey .. Goodman · Boston, MADirectorBrock Reeve · Boston, MADirectorShane .. Hegarty · Boston, MAExecJoanna Stanicka · Boston, MAExec · DirectorJonathan J. Leff · Boston, MADirectorRaymond J. Kelleher · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗